Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 9-15 , February 2008

Lung Cancer Screening: Promise and Pitfalls

  • Judith J. Smith

      Affiliations

    • Corresponding Author InformationAddress correspondence to Judith J. Smith, MSN, RN, AOCN®, Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, 6130 Executive Blvd, Room EPN 2134, Bethesda, MD 20892
    • ,
  • Christine D. Berg

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  2. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest. 1992;101:1013–1018
  3. Nesbitt J. Survival in early-stage lung cancer. Ann Thorac Surg. 1995;60:466–472
  4. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354:99–105
  5. Patz EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343:1627–1633
  6. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–1771
  7. Clark R, Reintgen D. Principles of screening. In:  Reintgen D,  Clark R editor. Cancer Screening. St. Louis, MO: Mosby; 1996;p. 1–20
  8. Miller A. Fundamental issues in screening for cancer. In:  Schottenfeld D,  Fraumeni JF editor. Cancer Epidemiology and Prevention. New York: Oxford University Press; 1996;p. 1433–1452
  9. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953–961
  10. US Department of Health and Human Services (US DHHS). National Lung Screening Trial- What is the appropriate measure of screening effectiveness? Available at: http://www.cancer.gov/nlst/what-is-nlst#10b (accessed September 12, 2007).
  11. Bach PB, Kelley MJ, Tate RC, et al. Screening for lung cancer: a review of the current literature. Chest. 2003;123(suppl 1):72S–82S
  12. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259–265
  13. Gohagan JK, Marcus PM, Fagerstrom RM, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005;47:9–15
  14. Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;126:114–121
  15. Tuchman M, Lemieux B, Auray-Blais C, et al. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics. 1990;86:765–773
  16. Woods WG, Tuchman M, Robison LL, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet. 1996;348:1682–1687
  17. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med. 1986;28:746–750
  18. Tockman MS. Lung cancer screening. The Johns Hopkins Study. 1986;89(suppl):324
  19. Melamed MR, Flehinger BJ, Zaman MB, et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984;86:44–53
  20. Sanderson D. Lung cancer screening: the Mayo study. Chest. 1986;89(suppl 4):324
  21. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308–1316
  22. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer. 1986;57:2427–2437
  23. Kubik AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89(suppl 11):2363–2368
  24. Gohagan JK, Prorok PC, Hayes RB, et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21(suppl 6):251S–272S
  25. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351:1242–1245
  26. Greenwald P. A favorable view: progress in cancer prevention and screening. Recent Results Cancer Res. 2007;174:3–17
  27. Bach PB, Silvestri GA, Hanger M, et al. Screening for lung cancer: AACP evidence-based clinical practice guidelines. Ed 2. Chest. 2007;132(suppl):69S–77S
  28. Humphrey L. Lung cancer screening: an update for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); May 2004;
  29. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321:323–329

PII: S0749-2081(07)00132-5

doi: 10.1016/j.soncn.2007.11.007

Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 9-15 , February 2008

Article Tools

* Image Usage & Resolution